RPRX
NASDAQStockRoyalty Pharma plc
$46.12-0.57 (-1.22%)
52-Week Range
$30.85
$47.48
Key Stats
Market Cap
19.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.42
Volume
2.4M
Avg Volume
3.3M
Performance
1M
+3.75%
3M
+19.48%
6M
+30.50%
YTD
+18.04%
1Y
+39.63%
3Y
+39.98%
5Y
-2.07%
Price Chart
ETF Exposure
RPRX is held by 188 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| REVS | Columbia Research Enhanced Value ETF | 0.28% |
| USCF | Themes US Cash Flow Champions ETF | 0.27% |
| VLUE | iShares MSCI USA Value Factor ETF | 0.26% |
| FNDA | Schwab Fundamental U.S. Small Company Index ETF | 0.25% |
| NUDV | Nuveen ESG Dividend | 0.25% |
| BSCU | Invesco BulletShares 2030 Corporate Bond ETF | 0.24% |
| IMCV | iShares Morningstar Mid-Cap Value ETF | 0.23% |
| JKI | iShares Morningstar Mid-Cap Value ETF | 0.23% |
| SIZE | iShares MSCI USA Size Factor ETF | 0.22% |
| BSCR | Invesco BulletShares 2027 Corporate Bond ETF | 0.21% |
| AVMC | Avantis U.S. Mid Cap Equity ETF | 0.20% |
| EQIN | Columbia U.S. Equity Income ETF | 0.20% |
| DURA | VanEck Durable High Dividend ETF | 0.20% |
| GSEW | Goldman Sachs Equal Weight U.S. Large Cap Equity ETF | 0.20% |
| GPAL | Goldman Sachs ActiveBeta Paris-Aligned U.S. Large Cap Equity ETF | 0.20% |
| SFLR | Innovator Equity Managed Floor ETF | 0.20% |
| VXF | Vanguard Extended Market ETF | 0.20% |
| EUSA | iShares MSCI USA Equal Weighted ETF | 0.19% |
| BSCY | Invesco BulletShares 2034 Corporate Bond ETF | 0.19% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.18% |
| GSLC | Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF | 0.18% |
| PTL | Inspire 500 ETF | 0.18% |
| HDV | iShares Core High Dividend ETF | 0.17% |
| XBFR | Innovator Equity Managed 10 Buffer ETF | 0.17% |
| EVUS | iShares ESG Aware MSCI USA Value ETF | 0.16% |
| FLCB | Franklin U.S. Core Bond ETF | 0.16% |
| AMCA | iShares Russell 1000 Pure U.S. Revenue ETF | 0.15% |
| CVMC | Calvert US Mid-Cap Core Responsible Index ETF | 0.15% |
| RECS | Columbia Research Enhanced Core ETF | 0.14% |
| IWR | iShares Russell Mid-Cap ETF | 0.14% |
| JHMM | John Hancock Investments - Multifactor Mid Cap ETF | 0.14% |
| BSCT | Invesco BulletShares 2029 Corporate Bond ETF | 0.14% |
| USNZ | Xtrackers Net Zero Pathway Paris Aligned US Equity ETF | 0.12% |
| IMCB | iShares Morningstar Mid-Cap ETF | 0.12% |
| JKG | iShares Morningstar Mid-Cap ETF | 0.12% |
| SCHI | Schwab 5-10 Year Corporate Bond ETF | 0.12% |
| CRBN | iShares Low Carbon Optimized MSCI ACWI ETF | 0.12% |
| FLQL | Franklin U.S. Large Cap Multifactor Index ETF | 0.11% |
| STXV | Strive 1000 Value ETF | 0.11% |
| PFIG | Invesco Fundamental Investment Grade Corporate Bond ETF | 0.11% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.10% |
| ESGU | iShares ESG Aware MSCI USA ETF | 0.10% |
| EQAL | Invesco Russell 1000 Equal Weight ETF | 0.10% |
| MFUS | PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF | 0.09% |
| IQSU | NYLI Candriam U.S. Large Cap Equity ETF | 0.09% |
| DIVB | iShares Core Dividend ETF | 0.09% |
| BDVL | iShares Disciplined Volatility Equity Active ETF | 0.09% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.09% |
| DGRO | iShares Core Dividend Growth ETF | 0.08% |
| USXF | iShares ESG Advanced MSCI USA ETF | 0.08% |
About RPRX ETF Exposure
Royalty Pharma plc (RPRX) is held by 188 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 19.8B, RPRX is a widely held institutional stock. The stock currently trades at $46.12. Investors can gain exposure to RPRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RPRX, sorted by portfolio weight.